Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01086397 · ClinicalTrials.gov registry record
Epidemiologic Study Of The Distribution Of Vaccine-Type Streptococcus Pneumoniae Serotypes In Adults In The US With Community-Acquired Pneumonia
A clinical trial of Vaccines, Pneumococcal and Pneumonia, Pneumococcal, sponsored by Pfizer.
- Completed
- Registry status
- 782
- Enrollment target
- 14
- Study locations
NCT01086397 is a study of Vaccines, Pneumococcal and Pneumonia, Pneumococcal that has completed, run by Pfizer. The registered enrollment target is 782 participants. The trial reports 14 study locations across 11 states.
The verdict
NCT01086397, a study of Vaccines, Pneumococcal and Pneumonia, Pneumococcal, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- 782 participants
- Enrollment target
- 14
- Study locations
Study Summary
The main purpose of this study is to use an investigational urine assay to estimate the proportion of pneumonia in adults 50 years or older in different areas throughout the US that is caused by certain types of the bacteria Streptococcus pneumoniae (also called pneumococcus).
Conditions Studied
Interventions
- PROCEDURE Urine sample collection
Study Locations (14)
Massachusetts
- Baystate Infectious Diseases Clinical Research - Springfield
- University of Massachusetts Memorial Medical Center - Worcester
- University of Massachusetts Memorial Medical Center - Worcester
Michigan
- Detroit Receiving Hospital - Detroit
- Sinai Grace Hospital - Detroit
Alabama
- University of South Alabama Division of Clinical Research - Mobile
California
- Sharpe-Grossmont Hospital - La Mesa
Florida
- Tampa General Hospital - Tampa
Illinois
- Northwestern Memorial Hospital - Chicago
Nevada
- eStudySite - Las Vegas
Ohio
- Summa Infectious Diseases - Akron
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 782 participants |
| Start Date | 2010-02 |
| Est. Completion | 2011-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01086397
The ClinicalTrials.gov registry entry for NCT01086397 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 782 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Vaccines, Pneumococcal appearing as the primary indexed condition, and to 1 intervention - of which Urine sample collection is the first listed.
NCT01086397 reports 14 study locations spanning 11 distinct geographic areas - top geographies include Massachusetts, Michigan, Alabama.
Frequently Asked Questions
What is clinical trial NCT01086397 about?
NCT01086397 is a clinical study titled "Epidemiologic Study Of The Distribution Of Vaccine-Type Streptococcus Pneumoniae Serotypes In Adults In The US With Community-Acquired Pneumonia". The main purpose of this study is to use an investigational urine assay to estimate the proportion of pneumonia in adults 50 years or older in different areas throughout the US that is caused by certain types of the bacteria Streptococcus pneumoniae (also called pneumococcus).
What is the current status of trial NCT01086397?
This trial is currently completed. The enrollment target is 782 participants. The study started on 2010-02. Estimated completion is 2011-10.
What conditions does trial NCT01086397 study?
This clinical trial studies the following conditions: Vaccines, Pneumococcal, Pneumonia, Pneumococcal.
What interventions are being tested in trial NCT01086397?
The interventions under investigation include: Urine sample collection (PROCEDURE).
Who is sponsoring clinical trial NCT01086397?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01086397 being conducted?
This trial has 14 study locations across Alabama, California, Florida, Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaccines, Pneumococcal
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.